Skip to main content

Vasculitis

      Long-Term Prognosis in Children with Kawasaki Disease: Dr. David Liew

      Dr. David Liew reviews abstract #0937 presented at the 2020 ACR annual meeting.

      RT @ejdein1: 4S013: Rheum Secrets and Pearls - Dr. Stone gives high yield vasculitis pearls. Always characterize by vess
      4 years ago
      4S013: Rheum Secrets and Pearls - Dr. Stone gives high yield vasculitis pearls. Always characterize by vessels size, get down to fat for adequate skin bx. #ACR20 @RheumNow https://t.co/WTzb9LsO6q
      RT @DrMiniDey: Time-trends analysis of in-hospital mortality in #vasculitis in the US shows it to have significantly dec
      4 years ago
      Time-trends analysis of in-hospital mortality in #vasculitis in the US shows it to have significantly declined in this population from 1998 to 2014. Abs#1423 #ACR20 @RheumNow https://t.co/TTI4DJiCRk
      RT @DrMiniDey: Patients diagnosed w/ #ANCA #vasculitis aged >75yrs have lower risk of relapse than pts 65-75yrs. Pts
      4 years ago
      Patients diagnosed w/ #ANCA #vasculitis aged >75yrs have lower risk of relapse than pts 65-75yrs. Pts >75yrs less likely to be treated w/ immunosuppression & steroids but do benefit from this treatment when it is required. Abs#1417 #ACR20 @RheumNow https://t.co/stTAcioiQG
      RT @drpnash: Feasibility of 18F-fluorodeoxyglucose Positron Emission Tomography to Monitor the Effect of Tocilizumab on
      4 years ago
      Feasibility of 18F-fluorodeoxyglucose Positron Emission Tomography to Monitor the Effect of Tocilizumab on Vascular Inflammation in Giant Cell Arteritis: A Prospective Observational Cohort Study https://t.co/Z91MhXJ5HK #gca #tocilizumab #pet what about the radiation?
      RT @MA_ALBA_vascul: @drdavidliew @VasculitisUMCG @RheumNow Dear David, thanks for your interest in our abstract #ACR20.
      @drdavidliew @VasculitisUMCG @RheumNow Dear David, thanks for your interest in our abstract #ACR20. This is based on some intriguing findings found in our previous observational study https://t.co/HKm53j2xou Still a work in progress but the potential adjunctive anti-inflammatory effect of ARBs seems attractive.
      RT @KilianMD: Pearls from @anisha_dua for differentiating atherosclerosis vs. vasculitis inflammation on imaging:

      1. Lo
      4 years ago
      Pearls from @anisha_dua for differentiating atherosclerosis vs. vasculitis inflammation on imaging: 1. Look at the Axillary arteries - they tend to be less likely affected by atherosclerosis 2. Vasculitic lesions tend to be concentric & longer/continuous #ACR20 #RheumTwitter
      RT @ELittlejohnDO: We need to start utilizing and normalizing anti phosphatidylserine/prothrombin antibody ordering in c
      We need to start utilizing and normalizing anti phosphatidylserine/prothrombin antibody ordering in clinical practice #ACR20 https://t.co/LeeHnuX9x0
      RT @esloanmd: Nice succinct review of recent DOAC studies in #APS by Dr. Ortel. Recommends avoiding DOACs in triple posi
      4 years ago
      Nice succinct review of recent DOAC studies in #APS by Dr. Ortel. Recommends avoiding DOACs in triple positive pts #antiphospholipid #ACR20 https://t.co/Hc6ye3mvTg
      RT @drdavidliew: Should ARBs be adjunct Rx in GCA?

      Plausible target:
      - previous pharmacoepi
      - ATII expressed in GCA inf
      4 years ago
      Should ARBs be adjunct Rx in GCA? Plausible target: - previous pharmacoepi - ATII expressed in GCA inflamm lesions - ATII induced pro-inflamm in PBMC/co-cultured VSMC - steroids modulate ATII expression in GCA TA ex vivo Maybe worth testing? Cid et al #ACR20 ABST0510 @RheumNow https://t.co/mNNzZVYe7g